Volume 45, no. 12, p. 3293-3303, 2001. Page 3295, Fig. 2: The R2 group in compound IV.19 should read CH2NHC6H(2-Br)(3,4,5-OMe)3.
. 2002 Mar;46(3):940.
Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptosporidium parvum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity Correlations
Richard G Nelson
1, Andre Rosowsky
1
Richard G Nelson
1Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California 94143, and Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Massachusetts 02115
Find articles by Richard G Nelson
Andre Rosowsky
1Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California 94143, and Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Massachusetts 02115
Find articles by Andre Rosowsky
1Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California 94143, and Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Massachusetts 02115
Copyright © 2002, American Society for Microbiology
PMCID: PMC127512
This corrects the article "Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptosporidium parvum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity Correlations" in volume 45 on page 3293.